Home / Companies / News / Hyderabad-based drug major Hetero prices Paxlovid generic at $60 per course

Hyderabad-based drug major Hetero prices Paxlovid generic at $60 per course

Generic version of Pfizer's Covid antiviral treatment would be exported for $70

Hetero seeks emergency use authorisation for Merck's antiviral drug

Premium

Hetero had entered into a non-exclusive voluntary licensing agreement with MPP for the manufacture and sale of a generic version of Pfizer’s Covid-19 oral antiviral in LMICs.

Sohini Das Mumbai

4 min read Last Updated : Dec 26 2022 | 7:54 PM IST

Hyderabad-based drug major Hetero has priced the generic version of Pfizer’s Covid antiviral treatment Paxlovid at $60 for the full course in India.

However, the company would export it for a price of $70 for a course comprising 30 tablets.

The company on Monday said it has emerged the first player globally to receive World Health Organisation’s (WHO) prequalification of medicines programme (WHO-PQ) for its generic version of Covid-19 oral antiviral treatment candidate Nirmatrelvir. This, along with Ritonavir, is used as part of Pfizer’s Paxlovid.

A Hetero source indicated that the company has already started production in batches of this

Topics : Hetero Group Coronavirus Vaccine Pharmaceutical companies World Health Organisation

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in